MarketTwits
265K subscribers
78.2K photos
2.93K videos
1.1K files
82.8K links
Вся информация на канале не является рекомендацией

связь - @MarketTwits_info
связь - [email protected]
VK - https://vk.com/id635239814

в подборках не участвуем, партнерки не практикуем, свой канал не рекламируем, менеджеры по рекламе не нужны
Download Telegram
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#THOR +167% Synthorx, Inc. -company announced it would be acquired by Sanofi for $68 per share in cash.

#XBIT +149% XBiotech Inc. - the company announced it would license its anti-inflammatory antibody to Janssen for $750 million in cash and up to $600 million in milestone payments.

#ARQL +102% ArQule, Inc. - the company agreed to be acquired by Merck & Co., Inc. #MRK for $20 per share in cash.

#OBSV +51% ObsEva SA - after reporting positive results from uterine fibroids Phase 3 study (PRIMROSE 2) of linzagolix.

#FATE +26% Fate Therapeutics, Inc. - the company disclosed that combination of FT596 with rituximab showed durable tumor clearance in vivo in preclinical lymphoma model at the ASH 2019.

#TGTX +24% TG Therapeutics, Inc. - the company announced a 100% overall response rate in its phase 1/2 study of ublituximab.

#PCG +21% PG&E Corporation - the company announced it reached a $13.5 billion settlement to resolve individual claims from recent fires including the 2018 Camp Fire and 2017 Tubbs fire.

#KRMD +12% Repro Med Systems, Inc.

#RRTS +11% Roadrunner Transportation Systems, Inc. - reported the sale of its Flatbed Business unit for $30 million in cash.

#SMLP +11% Summit Midstream Partners, LP

#FNV +8% Franco-Nevada Corporation

#BLUE +6% bluebird bio, Inc. - presented new data from ongoing Phase 1/2 HGB-206 study of LentiGlobin gene therapy for sickle cell disease at the ASH 2019.

#LPL +6% LG Display Co., Ltd.

ВНИЗ

#DPLO -32% Diplomat Pharmacy, Inc. -UnitedHealth Group Inc
#UNH announced plans to buy Diplomat Pharmacy for around $300 million.

#KALV -30% KalVista Pharmaceuticals, Inc. - the company disclosed that its Phase 2 trial of KVD001 did not meet its primary endpoint.

#DDOG -4% Datadog, Inc.

#KOS -4% Kosmos Energy Ltd

#DRIO -4% DarioHealth Corp.

#TGT -3% Target Corporation

#RDHL -3% RedHill Biopharma Ltd.
🇺🇸#DRIO DarioHealth, HMC HealthWorks announce partnership agreement

💥🇺🇸#DOW Dow Inc. price target raised to $55 from $52 at Truist

🇺🇸#RCII Rent-A-Center sees Q3 EPS 95c-$1.05, consensus 61c

🇺🇸#CPHI China Pharma obtains multiple certifications for masks